BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15013885)

  • 1. Validation of test duration as a screening criterion for frequency doubling perimetry.
    Thomas R; Parikh R; Muliyil J; Bhat S; George R
    Am J Ophthalmol; 2004 Mar; 137(3):562-3. PubMed ID: 15013885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma.
    Leeprechanon N; Giangiacomo A; Fontana H; Hoffman D; Caprioli J
    Am J Ophthalmol; 2007 Feb; 143(2):263-271. PubMed ID: 17178091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeatability of frequency doubling technology perimetry (20-1 screening program) and the effect of pupillary dilatation on interpretation.
    Parikh R; Muliyil J; George R; Bhat S; Thomas R
    Ophthalmic Epidemiol; 2008; 15(1):42-6. PubMed ID: 18300088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic sensitivity of fast blue-yellow and standard automated perimetry in early glaucoma: a comparison between different test programs.
    Bengtsson B; Heijl A
    Ophthalmology; 2006 Jul; 113(7):1092-7. PubMed ID: 16815399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH; Hutchison DM; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of diabetes on glaucoma screening using frequency-doubling perimetry.
    Realini T; Lai MQ; Barber L
    Ophthalmology; 2004 Nov; 111(11):2133-6. PubMed ID: 15522382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency-doubling technology: searching for the optimum diagnostic criteria for glaucoma.
    Ferreras A; Larrosa JM; Polo V; Pajarín AB; Mayoral F; Honrubia FM
    Acta Ophthalmol Scand; 2007 Feb; 85(1):73-9. PubMed ID: 17244214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency doubling perimetry and short-wavelength automated perimetry to detect early glaucoma.
    Leeprechanon N; Giaconi JA; Manassakorn A; Hoffman D; Caprioli J
    Ophthalmology; 2007 May; 114(5):931-7. PubMed ID: 17397926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of frequency-doubling technology, tendency-oriented perimetry, SITA Standard and SITA Fast perimetry in perimetrically inexperienced individuals.
    Pierre-Filho Pde T; Schimiti RB; de Vasconcellos JP; Costa VP
    Acta Ophthalmol Scand; 2006 Jun; 84(3):345-50. PubMed ID: 16704696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can frequency-doubling technology and short-wavelength automated perimetries detect visual field defects before standard automated perimetry in patients with preperimetric glaucoma?
    Ferreras A; Polo V; Larrosa JM; Pablo LE; Pajarin AB; Pueyo V; Honrubia FM
    J Glaucoma; 2007; 16(4):372-83. PubMed ID: 17571000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency doubling technology perimetry in open-angle glaucoma eyes with hemifield visual field damage: comparison of high-tension and normal-tension groups.
    Murata H; Tomidokoro A; Matsuo H; Tomita G; Araie M
    J Glaucoma; 2007 Jan; 16(1):9-13. PubMed ID: 17224743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated suprathreshold screening for glaucoma: the Baltimore Eye Survey.
    Katz J; Tielsch JM; Quigley HA; Javitt J; Witt K; Sommer A
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3271-7. PubMed ID: 8225862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [FDT versus automated standard perimetry in healthy subjects].
    Chiseliţa D; Ioana MC; Danielescu C; Mihaela NM
    Oftalmologia; 2006; 50(3):99-104. PubMed ID: 17144515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of frequency doubling perimetry in neuro-ophthalmic disorders: a comparison with conventional automated perimetry.
    Wall M; Neahring RK; Woodward KR
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1277-83. PubMed ID: 11923276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeatability of the Glaucoma Hemifield Test in automated perimetry.
    Katz J; Quigley HA; Sommer A
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1658-64. PubMed ID: 7601645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of efficient test procedures for frequency-doubling technology perimetry in normal and glaucomatous eyes.
    Turpin A; McKendrick AM; Johnson CA; Vingrys AJ
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):709-15. PubMed ID: 11867588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of standard automated perimetry with matrix frequency-doubling technology in patients with resolved optic neuritis.
    Sakai T; Matsushima M; Shikishima K; Kitahara K
    Ophthalmology; 2007 May; 114(5):949-56. PubMed ID: 17382395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.